|Articles|June 15, 2002
Newspaper reportRoche shareholders snub talk of Novartis merger
Basel, Switzerland-The Hoffmann and Oeri family heirs, who control a majority voting interest in Roche Holding AG although they own less than 10% of its equity, are reportedly not interested in merging the company with Novartis AG.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
3
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5














































.png)


